FDA Approves New Pfizer Biosimilar

Pfizerdeveloped biosimilar medicine IXIFI infliximabqbtx receives FDA approval for all eligible indications Pfizer Inc. NYSEPFE announced today that the United States U.S. Food and Drug Administration FDA has approved IXIFI PF064...